Status:
COMPLETED
Topical Ibuprofen for Delayed Onset Mulscle Soreness
Lead Sponsor:
Pfizer
Conditions:
Pain
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The objective of this study is to compare the efficacy and safety of Ibuprofen 5% Topical Gel versus placebo administered two or three times daily for the treatment of pain associated with delayed ons...
Eligibility Criteria
Inclusion
- Males or females, 18 to 65 years of age, who have not engaged in upper extremity fitness activities for a minimum of 3 months prior to entry in the study; subjects must be willing to refrain from use of pharmacologic or non pharmacologic treatments (ie, heat, ice, massage) and other forms of soreness relief during the study
Exclusion
- Use of corticosteroids or short- or long-acting non-steroidal anti-inflammatory drugs
Key Trial Info
Start Date :
June 13 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 29 2014
Estimated Enrollment :
205 Patients enrolled
Trial Details
Trial ID
NCT01794923
Start Date
June 13 2013
End Date
March 29 2014
Last Update
September 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Applied Pharmaceutical Research
Philadelphia, Pennsylvania, United States, 19145